Blockchain Registration Transaction Record

Instinct Bio Partners with Invitrx to Launch GENREVER in U.S., Boost Indonesia Regenerative Medicine

Instinct Bio partners with Invitrx to launch GENREVER cosmetics in the U.S. and advance regenerative medicine in Indonesia, leveraging Japanese innovation and U.S. GMP manufacturing.

This collaboration matters because it bridges Japanese cosmetic innovation with U.S. GMP manufacturing, potentially setting a new standard for premium skincare. For consumers, it may bring high-quality, scientifically-backed products to the U.S. market. For the regenerative medicine field, the Indonesia initiative could expand access to advanced therapies like exosome treatments in emerging healthcare markets, driving global health equity and innovation.